PUBLICATION

Novel neurotoxic peptides from Protopalythoa variabilis virtually interact with voltage-gated sodium channel and display anti-epilepsy and neuroprotective activities in zebrafish

Authors
Liao, Q., Li, S., Siu, S.W.I., Morlighem, J.R.L., Wong, C.T.T., Wang, X., Rádis-Baptista, G., Lee, S.M.
ID
ZDB-PUB-181020-9
Date
2018
Source
Archives of toxicology   93(1): 189-206 (Journal)
Registered Authors
Keywords
Anti-epilepsy, Disulfide bond, Neuroactive peptides, Neuroprotection, Protein docking, Voltage-gated sodium ion channel blocker
MeSH Terms
  • Amino Acid Sequence
  • Animals
  • Anthozoa/chemistry*
  • Anticonvulsants/pharmacology*
  • Heme Oxygenase (Decyclizing)/metabolism
  • Locomotion
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Neuroprotective Agents/pharmacology*
  • Nitric Oxide Synthase Type II/metabolism
  • Oxidopamine/adverse effects
  • PC12 Cells
  • Pentylenetetrazole/adverse effects
  • Peptides/chemical synthesis
  • Peptides/pharmacology*
  • Protein Structure, Tertiary
  • Rats
  • Reactive Oxygen Species/metabolism
  • Voltage-Gated Sodium Channel Blockers/pharmacology*
  • Voltage-Gated Sodium Channels/metabolism*
  • Zebrafish
PubMed
30334080 Full text @ Arch. Toxicol.
Abstract
We previously reported a novel toxic peptide identified from the anthozoan Protopalythoa variabilis transcriptome which is homologous to a novel structural type of sodium channel toxin isolated from a parental species (Palythoa caribaeorum). The peptide was named, according to its homologous, as Pp V-shape α-helical peptide (PpVα) in the present study. Through molecular docking and dynamics simulation, linear and hairpin folded PpVα peptides were shown to be potential voltage-gated sodium channel blockers. Nowadays, sodium channel blockers have been the mainstream of the pharmacological management of epileptic seizures. Also, sodium channel blockers could promote neuronal survival by reducing sodium influx and reducing the likelihood of calcium importation resulting in suppressing microglial activation and protecting dopaminergic neurons from degeneration. The folded PpVα peptide could decrease pentylenetetrazol (PTZ)-induced c-fos and npas4a expression level leading to reverse PTZ-induced locomotor hyperactivity in zebrafish model. In vitro, the folded PpVα peptide protected PC12 cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity via activating heme oxygenase-1 (HO-1) and attenuating inducible nitric oxide synthase (iNOS) expression. In vivo, PpVα peptide suppressed the 6-OHDA-induced neurotoxicity on the locomotive behavior of zebrafish and, importantly, prevented the 6-OHDA-induced excessive ROS generation and subsequent dopaminergic neurons loss. This study indicates that the single S-S bond folded PpVα peptide arises as a new structural template to develop sodium channel blockers and provides an insight on the peptide discovery from cnidarian transcriptome to potentially manage epilepsy and neurodegenerative disorders.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping